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AbstrAct:
Ischemia-reperfusion  injury  induces  intense  inflammatory  response  and  tissue 
damages resulting from the capacity of endogenous constituents called damage-
associated molecular patterns (DAMPs) released by damaged or necrotic cells, 
to activate signaling pathways mediated by receptors of the innate immune 
systems. Among them, two members of the Toll-like receptors (TLR) family, TLR2 
and  TLR4    have  been  shown  to  play  key  roles  in  the  induction  of  inflammatory 
response and cell apoptosis in a variety of ischemic tissues. The oxidative stress 
injury caused by I/R injury has been attributed to the activation of MAP kinase 
pathways, including those of ERK, JNK and p38. Here, we summarise recent 
findings concerning the role of the protein phosphatase 5 involved in the selective 
regulation  of  TLR2-mediated  ERK1/2  signaling  and  the  identification  of  the  key 
role of the  non-phagocytic NADPH oxidase 4  producing reactive oxygen species 
in the control of TLR4-mediated apoptosis in murine models of  renal I/R injury 
and in  post-hypoxic kidney tubule cells. The identification of molecules signaling 
involved in the ER stress-induced apoptotic signaling cascade may therefore 
represent potential targets to prevent the induction of apoptosis in hypoxic tissues. 
INtrODUctION
Ischemia/reperfusion (I/R) injury is a frequent 
event encountered in many pathophysiological situations, 
which results from complex interactions between reduced 
blood flow, production of reactive oxygen species (ROS) 
and activation of inflammatory processes that promote 
cell damage [1-3]. The initial sterile injury caused by 
I/R induces the activation of an innate immune response 
by pattern-recognition receptors. Among them, some 
members of the evolutionarily conserved family of Toll-
like receptor (TLR) family, which recognize distinct 
microbial components and mediate innate immune 
responses for host defense [4,5], also play key roles in 
the initiation of inflammation and cell damages caused by 
I/R injury [2]. The immune hematopoietic cells have been 
considered to play predominant roles in the induction and 
control of the innate immune response. However, there 
is now growing lines of evidence that epithelial mucosal 
cells, including hepatocytes, intestinal cells, pulmonary 
cells, and renal tubule cells, or cardiomyocytes, exhibit 
some, but not all, of the TLRs, primarily identified in 
leukocytes [6-10]. In addition, epithelial cells stimulated 
by TLR agonists or pathogens may develop potent TLR-
mediated inflammatory responses. These studies led to 
the emerging concept that epithelial cell, together with 
bone marrow-derived cells, are implicated in triggering 
an innate immune response to bacterial infection and/or 
ischemic stress [11,12]. 
TLR2 and TLR4 are constitutively expressed in 
bone marrow-derived cells and in a number of mucosal 
cells. A number of studies demonstrated that TLR4 play a 
key role in the mucosal inflammation caused by ischemia/
reperfusion (I/R) in hepatic I/R [6,13], intestinal I/R 
[14,15], cardiac I/R [16], and hemorrhagic shock [17,18]. 
A number of studies have shown that liver, intestine or 
kidneys from TLR4 deficient mice are better protected 
than that of TLR4 expressing wild-type mice subjected to 
liver, intestinal or renal I/R injury [6,15,19]. TLR2 have 
also been reported to mediate inflammatory responses and 
apoptosis during renal I/R injury [20]. Oncotarget 2010; 1:  741 - 750 742 www.impactjournals.com/oncotarget
Like other TLRS (except TLR3), TLR2 and TLR4 
exhibiting the co-adaptor MAL (or TIRAP) interact with 
adaptor myeloid differentiation factor 88 (MyD88). The 
recruitment of MyD88 facilitates the association of the 
Toll/IL-1R (TIR) domain with IL-1-receptor-associated 
kinases (IRAKs). Once phosphorylated, IRAKs become 
dissociated, and interact with TNF receptor-associated 
factor 6 (TRAF6) to activate TAK1, which then forms 
a complex with TK1 protein binding proteins, leading 
to the phosphorylation of the IκBs inhibitor proteins by 
IκB  kinases  (IKKs),  their  dissociation  and  subsequent 
degradation. This allows the transcription factor, NF-κB, 
to translocate into the nucleus [21,22]. Activation of TAK1 
also stimulates mitogen-activated protein kinase (MAPK) 
pathways including extracellular signal-regulated kinase 
(ERK), p38 MAP kinase, and c-jun N-terminal kinase 
(JNK) [23-25]. MyD88 deficient mice were also shown to 
be better protected against renal I/R injury than wild-type 
mice [26]. Concerning the kidney, experiments performed 
on intact post-ichemic kidneys and primary cultures of 
renal tubule epithelial cells (RTEC) also revealed that 
TLR2 and TLR4 both drive the inflammatory response 
and apoptosis [19,20], suggesting that TLR2 and TLR4 
are activated by endogenous ligands released by damaged 
cells to engage common or independent signaling 
pathways.
rOLE OF DAMAGE-AssOcIAtED 
MOLEcULAr PAttErNs IN tHE 
ActIVAtION OF tLr sIGNALING 
DUrING I/r INJUrY
The induction of non-bacterial, “sterile” inflammatory 
responses occurring during I/R results from the capacity 
of the so-called dammage-associated molecular patterns 
(DAMPs) to activate immune signaling pathways through 
TLR2 and/or 4. DAMPs can be classified as endogenous 
constituents released by damaged or necrotic cells, and as 
components of the extracellular matrix that are released 
by proteases [27]. A variety of DAMP constituents can 
activate TLR signaling. They include the high-mobility 
group box 1 (HMGB1) [28-30], heat shock proteins [31-
33],  fibrinogen  [34],  fibronectin  [35],  surfactant  [36],   
β-defensin [37], uric acid [38], hyaluronan [39], and the 
matrix components biglycan and heparan sulfate [40,41]. 
Most of them were shown to activate TLR2 and TLR4. 
Genomic DNA from dying cells also induces the maturation 
of antigen-presenting cells, and self-mRNA released from 
necrotic cells activates TLR3 [42,43]. HMGB1, which is 
ubiquitously expressed in eukaryotic cells, is a member 
of the non-histone, chromatin-associated, high-mobility 
group (HMG) family of proteins [44]. HMGB1 is released 
by all cells in a context of necrotic cell death [45], and 
can also be secreted by macrophages or dendritic cells in 
response to LPS, interferon-γ, and TNF-α [46]. The role of 
HMGB1 in the activation of TLR-mediated inflammatory 
reponse has been extensively studied in the context of 
I/R. The release of HMGB1 from cultured hepatocytes 
was shown to require intact TLR4, and be regulated by 
reactive oxygen species (ROS). HMGB1 was also shown 
to activate downstream calcium-dependent signaling 
pathways, since inhibition of the calcium/calmodulin-
dependent kinases (CMKs) reduces the release of HMGB1 
induced by oxidative stress in cultured hepatocytes 
[6].  Conversely,  inhibition  of  HMGB1  activity  with  a 
neutralising antibody markedly decreases the liver damage 
caused by I/R, whereas administration of recombinant 
HMGB1 worsened I/R-induced liver damages [6]. Similar 
observation have been made in experimental models 
of renal I/R: administration of blocking antibody to 
HMGB1 reduces renal tubule apoptosis and inflammatory 
responses caused by I/R, leading to the protection of renal 
function [47,48]. Interferon regulatory factor-1 (IRF-1) 
has been shown to contribute to the hepatocellular relase 
of  HMGB1  by  modulating  the  acetylation  of  HMGB1 
through the nuclear histone acetyltransferase 330 [49]. 
Futhermore, the increase in the levels of acetyled HMGB1 
is associated with concommitent decrease in nuclear 
histone deacetylase activity 1 and 4 [50], suggesting 
that the decrease in deacetylases 1 and 4 promotes the 
hyperacetylation and subsequent release of HMGB1 in 
hypoxic-stressed liver cells.
The signaling pathways activated downstream TLR2 
and/or TLR4 which triggers pro-inflammatory responses 
and apoptosis are however less well known. The oxidative 
stress injury caused by I/R injury has been attributed to 
the activation of MAP kinase pathways, including those 
of ERK, JNK and p38 [50,51]. The activation of JNK/
p38, via the activation of the Ser/Thr MAP kinase kinase, 
apoptosis  signal-regulating  kinase  1  (ASK1),  plays  a 
key role in cytokine- and stress-induced apoptosis [52-
54]. The activation of ERK is thought to be involved 
in cell survival, although its activation has also been 
shown to be associated with drug-induced apoptosis [55-
57]. Immunoblot analysis of total and phosphorylated 
ERK1/2, p38 and JNK MAP kinases in kidneys from 
wild-type, Tlr2-/- mice and Tlr4-/- mice subjected to I/R 
injury has revealed that I/R had almost no effect on p38 
(not shown). I/R failed to activate JNK in both Tlr2-/- 
mice and Tlr4-/- mice, but in sharp contrast, differentially 
activated ERK1/2 (Fig. 1A), since I/R injury stimulated 
the expression of phosphorylated (p-) ERK1/2 in post-
ischemic WT and Tlr4-/- kidneys, but not in Tlr2-/- kidneys 
[58]. IRI increased the expression level of TRAF2, and 
p-ASK1 and p-JNK, and a to much lesser extent p-p38 
(not shown) in day-1 post-ischemic wild-type kidneys, but 
not in post-ischemic Tlr2-/- and Tlr4-/- kidneys (Fig. 1A). 
In addition, the pro-apoptotic Bcl-2 homologue BAX (but 
not Bcl-2) also significantly increased in wild-type, but 
not in Tlr2-/- (not shown) and Tlr4-/-post-ischemic kidneys 
(Fig. 1B). Fig. 1C provides a schematic representation of Oncotarget 2010; 1:  741 - 750 743 www.impactjournals.com/oncotarget
the differential activation of TLR2- and TLR4-mediated 
ERK1/2 and JNK signaling pathways activated during 
I/R. As a result, the number of TUNEL-positive apoptotic 
cells  was  significanltly  less  in  in  post-ischemic  Tlr2-/-
and Tlr4-/- kidneys than in wild-type kidneys (Fig. 1D) 
[19,20,58]. Overall, these findings have demonstrated that 
TLR2 selectively controls ERK1/2, and that both TLR2 
and TLR4 mediates the activation of p-ASK1 and p-JNK, 
two key signal events responsible for apoptosis during 
IRI.
The following chapters will summarises the recent 
findings  concerning  the  mechanism  governing  the 
selective activation TLR2-mediqted ERK1/2 signaling 
and the mechanism controlling TLR4-mediated activation 
of pro-apoptotic pathways in post-ischemic kineys and 
primary cultures of renal tubule cells subjected to transient 
hypoxia.
sELEctIVE tLr2-MEDIAtED 
ActIVAtION OF ErK1/2 IN POst-
IsHEMIc KIDNEYs AND POst-HYPOXIc 
rENAL tUbULE cELLs: A rOLE FOr 
tHE PrOtEIN PHOsPHAtAsE 5
The activation of ERK has also been shown to be 
implicated in cell survival following oxidant injury 
or induction of endoplasmic reticulum (ER) stress-
induced cell death signaling [59-61]. A variety of protein 
phosphatases and protein kinases are involved in the 
regulation of signaling pathways by a phosphorylation/
dephosphorylation mechanism [62]. The protein 
phosphatase 5 (PP5), which is a member of the family of 
serine/threonine phosphatases is ubiquitously expressed 
in mammalian cells [63]. PP5 has been shown to act as a 
negative regulator of the apoptosis signal-regulating kinase 
1  (ASK1)-JNK/p38  pathway  that  facilitates  apoptosis 
in hypoxic and H2O2 stressed cell [64,65]. PP5 has been 
identified  as  an  inactivator  of  the  MEK-ERK  pathway 
through its interaction with the kinase Raf-1 initiating this 
pathway [66]. PP5 physically was also shown to interact 
with the heat shock protein (Hsp) 90 which is complexed 
with the transcription factor heat shock factor 1 (HSF1), 
a key regulatory protein involved in Hsp synthesis. This 
complex present in unstressed cells dissociates in stressed 
cells, and inhibition of complexed Hsp90 or dissociation 
Figure 1: tLr2- and tLr4-mediated activation of ErK and JNK MAP kinases during renal ischemia/reperfusion injury. 
(A) Immunoblot analysis of TRAF2 and β-actin, phospho (p-) and total ASK1, JNK, and ERK1/2 in control (C), and day-1 post-ischemic (I/R) 
wild-type, Tlr2-/-, and Tlr4-/- kidneys. (B) Immunoblot analysis of BAX and β-actin in control (C), and day-1 post-ischemic (I/R) wild-type 
(WT) and Tlr4-/- kidneys. (C) Diagram depicting TLR2- and TLR4-mediated activation of ERK and JNK in kidneys subjected to I/R injury. 
(D) Number of apoptotic TUNEL-positive cells in non-ischemic (C) and day (D)-1, D-2, and D-7 post-ischemic WT, Tlr2-/- and Tlr4-/- kidneys. 
Values are means ± SE. * < p < 0.05. Redrawn from refs 58 and 78. Oncotarget 2010; 1:  741 - 750 744 www.impactjournals.com/oncotarget
of the complex in condition of stress leads to an activation 
of  HSF1  [67-69].  We  have  shown  that  benzoquinone 
ansamycin geldanamycin (GA), which binds to Hsp90 
and destabilizes kinase complexes does not affect the 
phosphorylation state of p-ERK1/2 in control or post-
hypoxic wild-type and Tlr4-/- renal tubule cells, but in 
contrast, restores the phosphorylation of ERK1/2 in post-
hypoxic Tlr2-/- renal tubule cells [58]. On the other hand, 
GA had no effect on activated p-JNK in post-hypoxic 
wild-type RTECs, and did not restore the activation of 
phosphorylated JNK post-hypoxic Tlr2-/- RTECs as well 
as in post-hypoxic Tlr4-/- RTECs [58]. These findings have 
provided the first indication that gp96 play a key role in 
the induction of the TLR2-mediated activation of ERK1/2 
in post-hypoxic renal tubule cells.
gp96 (also called grp94), one of the most abundant 
ER-residing Hsp proteins, homologue of cytosolic Hsp90, 
plays a key role in TLR-mediated innate immunity [70,71]. 
Co-Immunoprecipiation studies revealed that gp96 co-
immunoprecipaited with PP5 in renal tubule cells The 
expression of gp96 increased significantly in renal tubule 
cells subjected to hypoxia [58]. Interestingly, PP5 does no 
longer physically interact with gp96 in post-hypoxic renal 
cells derived from wild-type kidneys, while it remains 
associated with gp96 in the protected, post-hypoxic 
Tlr2-/- renal cells [58] (Fig. 2A and 2B), suggesting that 
the disruption of the gp96-PP5 interaction leads to the 
inactivation of PP5. We reported that knock-down the 
gp96 protein by gp96 siRNA fully restored the activation 
of p-ERK1/2, but not of p-ASK1 and p-JNK, in the post-
hypoxic  Tlr2-/- renal tubule cells (Fig. 2C), indicating 
that gp96 plays a key role in controlling TLR2-mediated 
ERK activation in post-hypoxic renal tubule cells [58]. 
Furthermore, inhibition of PP5 by okadaic acid or silencing 
Pp5 siRNA restores the activation of p-ERK1/2 in Tlr2-/-
renal cells [58]. In a similar way, extinction of PP5 by 
Pp5 siRNA also reactivated ERK1/2 in post-hypoxic Tlr2-
/- renal cells, indicating that the selective TLR2-dependent 
activation of the ERK1/2 induced by hypoxia appears 
highly dependent on Pp5 activity in renal tubule cells 
[58]. PP5 associates with and inactivates ASK1 and JNK 
under redox stress [64,65]. Consistantly, the expression 
of p-JNK, as well as p-ASK1 dramatically increased in 
okadaic acid-pretreated and in in Pp5 siRNA-transfected 
Figure 2: role of the endoplasmic reticulum-resident gp96 and protein phosphatase 5 in the control of tLr2-mediated 
activation of ErK1/2 in hypoxic renal tubule cells. (A) Non-hypoxic (C) and day-1 post-hypoxic (H) wild-type (WT) or Tlr2-/- renal 
tubule cells were subjected to immunoprecipitation (IP) using an antibody against gp96, and proteins were detected using an anti-protein 
phosphatase 5 (PP5) antibody. (B) Schematic representation of the PP5-dependent activation of ERK1/2 in non-hypoxic and post-hypoxic 
WT and Tlr2-/- renal tubule cells. (C, D) Immunoblot analyses of p- and total ERK1/2 (C) or total and p-ASK1 and -JNK (D) in non-hypoxic 
(Control) and 24 h post-hypoxic (Hypoxia) Tlr2-/- renal tubule cells transfected (+) or not (-) with specific gp96 siRNA (C) or Pp5 siRNA. (E) 
Percentage of apoptotic cells measured in non-hypoxic (Control) or day-1 post-hypoxic (Hypoxia) Tlr2-/- RTECs transfected or not with a Pp5 
siRNA or negative control siRNA. Values are means ± SE. * p < 0.05 between groups. (F) Schematic representation of the TLR2-mediated 
ERK activation in post-hypoxic renal tubule cells. Hypoxia stimulates gp96, but does not induce the dissociation of gp96 bound to PP5 in Tlr2-
/- deficient renal tubule cells. Inhibition of gp96 activity by geldanamycin, or knockdown gp96 mRNA induces the reactivation of ERK1/2, but 
not of JNK or ASK1 in Tlr2-/- deficient RTECs. Extinction of Pp5 mRNA expression also induces the reactivation of p-ERK1/2 and p-JNK. 
Redrawn from ref 58. Oncotarget 2010; 1:  741 - 750 745 www.impactjournals.com/oncotarget
Tlr2-/- renal cells subjected to hypoxia (Fig. 2D). As a 
result, silencing Pp5 mRNA expression also reactivates 
apoptosis in post-hypoxic Tlr2-/- renal tubule cells (Fig. 
2E). Fig. 2F summarizes the possible mechanism of PP5-
dependent inactivation/activation of ERK1/2 in non-
hypoxic and post-hypoxic renal tubule cells.
tLr4-MEDIAtED APOPtOsIs IN POst-
HYPOXIc rENAL tUbULE cELLs: A 
rOLE FOr tHE NADPH OXIDAsE 4 
PrODUcING rOs
ROS-induced cell injury has been attributed in part 
to activation of mitogen-activated protein kinase (MAPK) 
pathways [72]. Members of the NAD(P)H oxidase (NOX) 
family  producing  ROS,  which  are  homologues  of  the 
gp91phox catalytic subunit of phagocytic NAD(P)H oxidase 
(NOX2),  have  been  shown  to  be  involved  in  cellular 
functions related to innate immunity, signal transduction, 
proliferation,  and/or  apoptosis  [73].  Among  the  NOX 
isoforms,  NOX4  was  shown  to  be  required  for  LPS-
induced H2O2 generation in TLR4-expressing HEK 293T 
cells, and to interact directly with TLR4 in regulating 
NF-κB  activation  [74].  NOX4,  which  is  sthough  to 
constituvely produce ROS [73,75] is the most abundantly 
NOX isform expressed within kidneys [76,77]. Recently, 
we have shown that the mouse kidney express both the full-
Figure 3: role of gp96 and NOX4 in the activation of tLr4-mediated apoptosis in hypoxic renal tubule cells. (A) 
Immunoblot analysis of the 28 kDa NOX4 isoform in control (C) and day-1 post-hypoxic (H) wild-type (WT) and Tlr4-/- renal tubule cells. (B) 
ROS production in non-hypoxic (Control) and post-hypoxic (Hypoxia) wild-type RTECs transfected (+) or not (-) with specific Nox4 siRNAs, 
which target sequences encoding both the full length 65-kDa and the 28-kDa isoform (Nox465-28) or only the 28-kDa NOX4 isoform (Nox428). 
(C) ) Immunoprecipitated lysates from non-hypoxic (C) or 24 h post-hypoxic (H) wild-type renal tubule cells using an anti-gp96 antibody were 
subjected to Western blot analysis using anti-TLR4 or NOX4 antibodies. (D) Percentage of apoptotic cells in non-hypoxic (Control) and day-1 
post-hypoxic (Hypoxia) wild-type renal tubule cells and in post-hypoxic cells transfected (+) ot not (-) with specific Traf2, gp96, or the two 
Nox465-28 or Nox428 siRNAs, or incubated with (+) or without (-) the JNK inhibitor SP600125 or the ERK inhibitor SB203580. Values are means 
± SE. * p < 0.05 between groups. (E) Schematic representation of the TLR4-mediated activation of ASK1/JNK inducing apoptosis. Hypoxia 
activates NOX4 producing ROS which induces the dissociation of thioredoxine from endogenous ASK1. Redrawn from ref 78.Oncotarget 2010; 1:  741 - 750 746 www.impactjournals.com/oncotarget
lenght 65-kDa NOX4 protein, and also a 28-kDa NOX4 
isoform [78], similar to a the human NOX4 D variant 
lacking exons 3-11 with a predicted molecular weight of 
28-kDa [79]. We also showed that hypoxia stimulates the 
expression of the 28 kDa isoform in wild-type renal tubule 
cells (Fig. 3A) and that silencing both the full length 65-
kDa and 28-kDa Nox4 mRNAs or only the 28-kDa Nox4 
mRNA isoform prevented both the induction of ROS in 
post-hypoxic  wild-type  cells  (Fig.  3B),  suggesting  that 
the 28-kDa NOX4 isoform play a role in the induction of 
TLR4-mediated apoptosis caused by I/R injury.
INtErPLAYs bEtWEEN tLr4, GP96, 
AND NOX4 IN tLr4-MEDIAtED 
ActIVAtION OF PrO-APOPtOtIc 
sIGNALING INDUcED bY HYPOXIA
Tlr4-/- post-ischemic kidneys and post-hypoxic renal 
tubule  cells  exhibit  significantly  less  active  caspase-3 
positive  apoptotic  cells  and  produce  less  ROS  than  in 
the corresponding wild-type post-ischemic kidneys and 
post-hypoxic renal tubule cells [19,78]. Like in TLR4-
transfected HEK 293 cells, TLR4 interacts NOX4 [79] 
and with gp96 in non-hypoxic renal tubule cells, but TLR4 
does not binds with gp96 and hypoxia did not alter the 
physical interaction between TLR4 and NOX4 [78]. These 
findings are summarized in Fig. 3C. However, silencing 
gp96 mRNA expression prevented the increase in TRAF2, 
p-ASK1  and  p-JNK  in  post-hypoxic  wild-type  renal 
tubule cells, a well as ROS production and induction of 
apoptosis [78]. Co-immunoprecipitation experiments also 
revealed that TRAF2, which is not associated with ASK1 
in non-hypoxic renal tubule cells, co-immunoprecipitates 
with ASK1 upon hypoxia [78]. These data have confirmed 
that endogenous TLR4 binds with NOX4 in intact renal 
tubule cells, and also provided strong evidence that the 
ER-resident gp96 play a key role in the activation of 
TRAF2-mediated signaling pathway downstream TLR4. 
Silencing Traf2 mRNA expression almost fully impaired 
the activation of NOX4, p-ASK1 and p-JNK and ROS 
production in post-hypoxic wild-type renal tubule cells 
[78]. Consistantly, the induction of apoptosis was no 
longer detected in Traf2 siRNA-transfected WT renal 
tubule  cells  subjected  to  hypoxia  (Fig.  3D).  Silencing 
Nox428 siRNA expression does not prevent the activation 
of TRAF2 in post-hypoxic, wild-type renal tubule cells, 
but  impairs  the  hypoxia-induced  activation  of  p-ASK1 
and p-JNK [78]. Silencing NOX4 RNAs encoding the the 
full lengt 65 kDa or the 28 kDa isoform using specific 
NOX465-28 and Nox428 siRNAs, respectively, also fully 
impaired the induction of apoptosis and ROS production 
in post-hypxic wWT renal tubule cells (Fig. 3D) [78]. 
Using JNK and p38 inhibitors, we also showed that JNK 
can reciprocally regulate NOX4 and prevent the induction 
of ROS production and cell apoptosis caused by hypoxia 
[78]. Inhibition of JNK appears to be more efficient that 
the inhibition of p-p38 to reduce apoptosis induced by 
hypoxia (Fig. 3D). Moreover, concomittent inhibition of 
JNK and p38 had additive effects on apoptosis inhibition 
(Fg. 3D), suggesting that both JNK, and to a lesser extend 
p38, are involved in the induction of apoptotic signaling 
activated by hypoxia. Fig. 3E provides a schematic 
representation of the proposed mechanism of the TLR4/
NOX4-mediated  activation  of  the  TRAF2/ASK1/JNK 
apoptotic pathway induced by hypoxia.
cONcLUsIONs
Activation of both TLR2 and TLR4 signaling during 
I/R  injury  induces  potent  inflammatory  response  and 
induction of cell apoptosis. Studies on renal I/R injury have 
revealed that TLR2 selectively stimulated the ERK1/2 
through  specific  interactions  between  the  ER-resident 
gp96 chaperone and the protein phosphatase 5. Activation 
of TLR4 signaling promotes the activation of the TRAF2/
ASK1/JNK pro-apoptotic pathway. In the kidney, the non-
phagocytic NOX4 which physically interacts with NOX4 
appears to play a key role in the induction of aptoptosis. 
However, a number of question still remains to be solved. 
There  are  multiple  source  of  ROS  production  during 
hypoxia, including the mitochondrial respiratory chain, 
xanthine oxidase, xanthine-oxygenase, lipoxygenase, 
and NOX enzymes in stressed cells [80]. Although the 
28-kDa NOX4 isform appears to play a key role in the 
control of apoptosis in post-hypoxic renal tubule cells, the 
question arises wether this Nox4 isoform lacking most 
transmembrane domains [79], is also directly involved 
in the ROS production induced by hypoxia. NOX4 has 
been shown to be involved in the up-regulation of the 
hypoxia-induced transcription factor HIF-1α [81], a key 
regulator of oxygen-regulated gene expression [82]. 
Conversely, the induction of NOX4 by HIF-1α also shown 
to maintain sustain levels of ROS after hypoxia [83]. The 
question arises to know as to whether NOX4 interacts 
with  TLR4  and  whether  NOX4  plays  a  role  a  in  the 
control of cell apoptosis in other tissue² than the kidney. 
The identification of NOX4 as a sensor in the ER stress-
induced, TLR4-mediated, pro-apoptotic signaling cascade 
should has implications for selective anti-superoxide-
generating enzyme strategies intended to prevent the the 
induction of apoptosis in hypoxic tissues. 
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